stan_musial

Egalet appoints Stan Musial as CFO

pharmafile | May 10, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing |  Egalet, musial 

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer. 

Bob Radie, president and chief executive of Egalet said: “Stan’s finance experience will be invaluable as we move our pipeline through development and ultimately to the commercial market.”

Musial has held senior financial management positions for both publicly-held and privately-held companies and has experience in executing growth strategies, raising capital, and mergers and acquisitions. 

Advertisement

He most recently spent six years as vice president of finance and administration, chief financial officer, treasurer and secretary of Prism Pharmaceuticals, a speciality pharma company, which was successfully sold to Baxter Healthcare in 2011.  

Prior to joining Prism he held the position of vice president, finance, and CFO for Strategic Diagnostics, a publicly-held biotech firm. He began his career with KPMG LLP.  

“I am excited to join Egalet – a company seeking to advance its pipeline of abuse deterrent opioids by taking advantage of the expedited 505(b)(2) regulatory pathway to address the growing need for safe pain medicines,” added Musial. 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content